Flagship Pioneering Launches Expedition Medicines with $50M to Revolutionize AI-Driven Drug Discovery
Flagship Pioneering introduces Expedition Medicines, backed by $50M funding, employing AI and covalent chemistry to develop new treatments for cancer and immune diseases with Pfizer collaboration.










